Effect of a Sugar-Free Chewing Gum Containing Magnolia Bark Extract on Caries Lesions in Healthy Adult Volunteers
Effect of a Sugar-free Chewing Gum Containing Magnolia Bark Extract on the Development of Caries Lesions in Healthy Adult Volunteers: a Randomized Controlled Intervention Trial
1 other identifier
interventional
480
1 country
2
Brief Summary
The effect of chewing gums containing MBE and xylitol on different variables related to caries and gingivitis in a sample of adult volunteers with a high risk for caries will be evaluated. The main result of that double-blind randomized controlled interventional trial will be that chewing gum containing MBE was more effective in reducing plaque acidogenicity, salivary mutans streptococci concentration and gingival bleeding compared to a xylitol and sugar-free chewing gum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 24, 2014
CompletedFirst Posted
Study publicly available on registry
December 8, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedDecember 8, 2014
December 1, 2014
2.6 years
November 24, 2014
December 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
International Caries Detection and Assessment System (ICDAS) increment
cumulative D2 or Filled Surface (D2 FS) increment (root and coronal surfaces combined).
24 months
Secondary Outcomes (2)
Salivary mutants streptococci and lactobacilli counts
6-12-24 months
Modification of plaque pH
6-12-24 months
Study Arms (3)
xylitol chewing gum
ACTIVE COMPARATORIntervention chewing gum administration Each subject will be instructed to chew 1 or 2 pellets for 5 min 3 times a day (2 in the morning, 2 after the midday meal and 1 in the afternoon). Thus, the total daily intake of magnolol and honokiol in MX group will be 11.9 mg/day. The daily use of the two different chewing gums will be carried out for 12 months.
Xylitol-magnolia chewing gum
EXPERIMENTALIntervention chewing gum administration Each subject will be instructed to chew 1 or 2 pellets for 5 min 3 times a day (2 in the morning, 2 after the midday meal and 1 in the afternoon). Thus, the total daily intake of magnolol and honokiol in MX group will be 11.9 mg/day. The daily use of the two different chewing gums will be carried out for 12 months.
Control chewing gum
PLACEBO COMPARATORIntervention chewing gum Each subject will be instructed to chew 1 or 2 pellets for 5 min 3 times a day (2 in the morning, 2 after the midday meal and 1 in the afternoon). Thus, the total daily intake of magnolol and honokiol in MX group will be 11.9 mg/day. The daily use of the two different chewing gums will be carried out for 12 months.
Interventions
Intervention chewing gum Each subject will be instructed to chew 1 or 2 pellets for 5 min 3 times a day (2 in the morning, 2 after the midday meal and 1 in the afternoon). Thus, the total daily intake of magnolol and honokiol in MX group will be 11.9 mg/day. The daily use of the two different chewing gums will be carried out for 12 months.
Eligibility Criteria
You may qualify if:
- Age 30-45
- Presence of a minimum of 12 natural teeth
- At least one surface cavitated caries lesion, but no more than three
- Mutans streptococci and Lactobacilli \>105 CFU/ml saliva
- Systemically healthy as assessed by a medical questionnaire
- No use of antibiotics or participation in a clinical study in the previous 30 days
- No allergy to any of the ingredients of the study products
- No orthodontic banding or removable prosthesis
- Moderate gingivitis, no current periodontitis (no sites of probing pocket depth ≥5 mm or attachment loss of ≥2 mm, apart from gingival recession).
- Absence of dysfunction of temporo-mandibular joint.
You may not qualify if:
- Subjects with a history of GI problems and with systemic disease that interfered with the oral ecosystem were excluded. The caries criterion was designed to include participants who are at risk of forming new lesions.
- In addition, those participants who were already consuming more than three pieces of sugar-free chewing gum a day were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Surgery, Microsurgery and Medicine Sciences University of Sassari
Sassari, Sardinia, I-07100, Italy
WHO CC University of Milan
Milan, I-20121, Italy
Related Publications (1)
Cocco F, Carta G, Cagetti MG, Strohmenger L, Lingstrom P, Campus G. The caries preventive effect of 1-year use of low-dose xylitol chewing gum. A randomized placebo-controlled clinical trial in high-caries-risk adults. Clin Oral Investig. 2017 Dec;21(9):2733-2740. doi: 10.1007/s00784-017-2075-5. Epub 2017 Mar 16.
PMID: 28303470DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor in Community Dentistry
Study Record Dates
First Submitted
November 24, 2014
First Posted
December 8, 2014
Study Start
April 1, 2012
Primary Completion
November 1, 2014
Study Completion
November 1, 2015
Last Updated
December 8, 2014
Record last verified: 2014-12